Cargando…

Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules

Bispecific T cell receptor (TCR)-based molecules capable of redirecting and activating T cells towards tumor cells represent a novel and promising class of biotherapeutics for the treatment of cancer. Usage of TCRs allows for targeting of intracellularly expressed and highly selective cancer antigen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dilchert, Janine, Hofmann, Martin, Unverdorben, Felix, Kontermann, Roland, Bunk, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150015/ https://www.ncbi.nlm.nih.gov/pubmed/35645207 http://dx.doi.org/10.3390/antib11020034

Ejemplares similares

The making of bispecific antibodies
por: Brinkmann, Ulrich, et al.
Publicado: (2017)

Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
por: van Diest, Eline, et al.
Publicado: (2021)

eIg-based bispecific T-cell engagers targeting EGFR: Format matters
por: Kühl, Lennart, et al.
Publicado: (2023)

The eIg technology to generate Ig-like bispecific antibodies
por: Kühl, Lennart, et al.
Publicado: (2022)

Correction: Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
Publicado: (2021)

TCR-mimic bispecific antibodies to target the HIV-1 reservoir
por: Sengupta, Srona, et al.
Publicado: (2022)

A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3
por: Rau, Alexander, et al.
Publicado: (2021)

Affinity maturation of TCR-like antibodies using phage display guided by structural modeling
por: Frick, Rahel, et al.
Publicado: (2022)

A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells
por: Aschmoneit, Nadine, et al.
Publicado: (2021)

Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response
por: Sapski, Sabrina, et al.
Publicado: (2020)

Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release
por: Aschmoneit, Nadine, et al.
Publicado: (2021)

A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties
por: Unverdorben, Felix, et al.
Publicado: (2015)

BEAT(® )the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs
por: Moretti, Pierre, et al.
Publicado: (2013)

Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors
por: Kuklik, Juliane, et al.
Publicado: (2021)

The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers
por: van Diest, Eline, et al.
Publicado: (2023)

Targeting the Tumor Microenvironment with Fluorescence-Activatable Bispecific Endoglin/Fibroblast Activation Protein Targeting Liposomes
por: Tansi, Felista L., et al.
Publicado: (2020)

Tethered-variable C(L) bispecific IgG: an antibody platform for rapid bispecific antibody screening
por: Kim, Hok Seon, et al.
Publicado: (2017)

CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins
por: Jost, Christian, et al.
Publicado: (2020)

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
por: Weth, R, et al.
Publicado: (2004)

YEAST SURFACE DISPLAY OF FULL-LENGTH IGG FOR ENGINEERING MONOCLONAL AND BISPECIFIC ANTIBODIES
por: Jiang, Youwei
Publicado: (2023)

Enhancers Improve the AID-Induced Hypermutation in Episomal Vector for Antibody Affinity Maturation in Mammalian Cell Display
por: Chen, Chuan, et al.
Publicado: (2018)

Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins
por: Misson Mindrebo, Laetitia, et al.
Publicado: (2023)

A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
por: Xu, Yiyang, et al.
Publicado: (2018)

Maturation of the mammalian secretome
por: Simpson, Jeremy C, et al.
Publicado: (2007)

Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform
por: Huhtinen, Olli, et al.
Publicado: (2023)

Bispecific antibody-derived molecules to target persistent HIV infection
por: Nordstrom, Jeffrey L., et al.
Publicado: (2022)

Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations
por: Bai, Zixuan, et al.
Publicado: (2022)

Construction of a Mammalian IRES-based Expression Vector to Amplify a Bispecific Antibody; Blinatumomab
por: Naddafi, Fatemeh, et al.
Publicado: (2019)

Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies
por: Yang, Fa, et al.
Publicado: (2016)

Leveraging a physiologically-based quantitative translational modeling platform for designing B cell maturation antigen-targeting bispecific T cell engagers for treatment of multiple myeloma
por: Yoneyama, Tomoki, et al.
Publicado: (2022)

Characterization of a Novel Single-Chain Bispecific Antibody for Retargeting of T Cells to Tumor Cells via the TCR Co-Receptor CD8
por: Michalk, Irene, et al.
Publicado: (2014)

Inherent reactivity of unselected TCR repertoires to peptide-MHC molecules
por: Krovi, S. Harsha, et al.
Publicado: (2019)

“First AID” for T cell adoptive transfer: TCR affinity maturation by somatic hypermutation
por: Gozlan, Yosi M, et al.
Publicado: (2013)

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals
por: Philipp, Nora, et al.
Publicado: (2022)

Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells
por: Dillon, Michael, et al.
Publicado: (2016)

A novel and effective approach to generate germline-like monoclonal antibodies by integration of phage and mammalian cell display platforms
por: Jin, Yu-jia, et al.
Publicado: (2021)

Bispecific Antibody Molecule Inhibits Tumor Cell Proliferation More Efficiently Than the Two-Molecule Combination
por: Volk, Anna-Luisa, et al.
Publicado: (2021)

OVERCOMING TECHNICAL CHALLENGES OF BISPECIFIC AND MULTI-SPECIFIC ANTIBODIES USING NOVEL TECHNOLOGY PLATFORMS
por: Xu, Jianqing, et al.
Publicado: (2023)

Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc)
por: Aschmoneit, Nadine, et al.
Publicado: (2022)

Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_cvg9aofo3qn3l0c62oc544pj9e